Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and safety of one intravitreal injection of bevacizumab in diabetic macular oedema

Published:2008-06-28 Issue:7 Volume:86 Page:800-805
ISSN:1755-375X
Container-title:Acta Ophthalmologica
language:en
Short-container-title:

Author:

Fang Xiaoyun,Sakaguchi Hirokazu,Gomi Fumi,Oshima Yusuke,Sawa Miki,Tsujikawa Motokazu,Ikuno Yasushi,Kamei Motohiro,Kusaka Shunji,Tano Yasuo

Publisher

Wiley

Subject

Ophthalmology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1755-3768.2008.01254.x/fullpdf

Reference27 articles.

1. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders;Aiello;N Engl J Med,1994

2. Pan-American Collaborative Retina Study Group. Primary intravitreal bevacizumab (Avastin) for diabetic macular oedema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up;Arevalo;Ophthalmology,2007

3. Intravitreal bevacizumab (Avastin) for the treatment of proliferative diabetic retinopathy;Avery;Ophthalmology,2006

4. Pharmacokinetics of intravitreal bevacizumab (Avastin);Bakri;Ophthalmology,2007

5. Difference in clearance of intravitreal triamcinolone acetonide between vitrectomized and non-vitrectomized eyes;Chin;Retina,2005

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, safety, and cost-effectiveness of biosimilars of bevacizumab in näive patients with diabetic macular edema;Indian Journal of Pharmacology;2024-07

2. Clinical outcomes and associated risk factors of cataract surgeries in patients with diabetic macular edema: A real-world study;Nigerian Journal of Vitreoretinal Diseases;2023

3. Relationship Between Macular Thickness and Visual Acuity in the Treatment of Diabetic Macular Edema With Anti-VEGF Therapy: Systematic Review;Journal of VitreoRetinal Diseases;2022-11-18

4. Alone laser versus bevacizumab plus laser for diffuse diabetic macular edema (ALBA randomized trial);Therapeutic Advances in Ophthalmology;2021-01

5. The Short-Term Efficacy of Biweekly Subconjunctival Bevacizumab in Diabetic Macular Edema;Current Eye Research;2019-10-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3